from Reuters: Health News https://reut.rs/2HbDAZA
Sunday, May 12, 2019
Sunday, May 12, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that its therapy can completely prevent headaches in a small percentage of patients.

from Reuters: Health News https://reut.rs/2HbDAZA
from Reuters: Health News https://reut.rs/2HbDAZA
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment